Pfizer offers settlement in class action over Parkinson’s drug CabaserCompany has offered to settle a class action brought by more than 150 patients in Australia who allege they were never warned about the side effects of treatment.…
EURMED launched to facilitate medicines donations in response to global appealsAn initiative described as a “step change” in the ability of the European pharmaceutical industry to donate medicines in response to global disasters or appeals for humanitarian aid has been launched.…
GlaxoSmithKline revises colour and labelling of Relvar Ellipta inhaler GlaxoSmithKline is changing the colour of its Relvar Ellipta inhaler from blue to yellow after respiratory health professionals warned that patients could be confused.…
France, Germany, Belgium and Luxembourg suspend drug licences for some GVK Biosciences generics Four European countries have suspended the marketing authorisations for 25 generic medicines tested by GVK Biosciences at its plant in Hyderabad, India.…
Survey suggests US doctors are changing their prescribing habits for opioid drugsMany primary care physicians are less likely to prescribe opioids now than a year ago, according to a survey of US doctors.…
Review examines link between paracetamol use and asthma Researchers observed a positive association between paracetamol use in pregnancy and asthma but were unable to find sufficient evidence to support a change in guidance.…
EMA says flu vaccine is safe after deaths in ItalyThere is no evidence that Novartis’s Fluad is unsafe, the European Medicines Agency (EMA) says, after 13 deaths in Italy were reported as being associated with the influenza vaccine.…
Initial Fluad investigations find no manufacturing defectPreliminary investigations have found no manufacturing defect in the influenza vaccine Fluad, which has been linked to the deaths of 13 older people in Italy.…
Ibrutinib launched for treatment of mantle cell lymphoma and chronic lymphocytic leukaemia Ibrutinib, a Bruton’s tyrosine kinase inhibitor, has been launched in the UK for the treatment of mantle cell lymphoma or chronic lymphocytic leukaemia.…
Medicines regulator amends conflict of interest rules to ensure suitability of experts The European Medicines Agency has amended its policy on handling declarations of interest to ensure pharmaceutical experts are not unduly excluded.…
